Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life
0.50 hr(s) | CME
Specialty: Psoriasis
Therapeutic Area(s): Dermatology
Release Date: March 25, 2021
Expiration Date: March 24, 2022
Location: Internet Activity Enduring
In this activity, an expert in dermatology discusses the role of IL-17 inhibitors in the treatment of psoriasis.